Stockholders' Deficiency (Details Narrative) - USD ($)		3 Months Ended		6 Months Ended		12 Months Ended
	Jan. 07, 2019	Jan. 31, 2019	Jan. 31, 2018	Jan. 31, 2019	Jan. 31, 2018	Jul. 31, 2018	Dec. 01, 2018	Nov. 30, 2018	Nov. 27, 2018	Oct. 26, 2018	Mar. 27, 2017	Feb. 28, 2017	Feb. 09, 2017	Jan. 31, 2017	Jan. 18, 2017
Common stock issued		60,362,164		60,362,164		22,430,121				4,830,000			2,179,989		1,117,011
Acquisition in HDS															51.00%
Shares of common stock, obligated to issue															4,830,000
Common stock purchase warrants, exercise price													$ 0.35
Common stock payable, Shares				1,238,517
Common stock payable, Amount				$ 201,294
Warrants exercised, shares													6,607,629
Net (loss) attributable to noncontrolling interests		$ (272,147)	$ (92,934)	(360,403)	$ (209,467)
Investment in subsidiary by noncontrolling interest				133,679	$ 125,376	$ 327,593
Non-controlling interest		$ 21,683,698		$ 21,683,698		$ (5,576,272)
Series H Convertible Preferred Stock
Common stock issued upon conversion of preferred stock		25,200,000		25,200,000
Convertible preferred stock, shares authorized		109,000		109,000		109,000
Convertible preferred stock, par value (in dollars per share)		$ 0.001		$ 0.001		$ 0.001
Convertible preferred stock, shares issued		0		0		63,000					63,000
Convertible preferred stock shares issued value						$ 3					$ 3,000,000
Series I Convertible Preferred Stock
Convertible preferred stock, shares authorized		6,000		6,000		6,000
Convertible preferred stock, par value (in dollars per share)		$ 0.001		$ 0.001		$ 0.001
Convertible preferred stock, shares issued		0		0		6,000
Convertible preferred stock shares issued value						$ 1
Olaregen Series A Preferred Stock [Member]
Convertible preferred stock, shares authorized		592,683		592,683		0
Convertible preferred stock, par value (in dollars per share)		$ 0.001		$ 0.001		$ 0.001
Convertible preferred stock, shares issued		592,683		592,683		0
Convertible preferred stock shares issued value
Regentys Series A Redeemable Convertible Preferred Stock [Member]
Convertible preferred stock, shares authorized		2,793,192		2,793,192		2,793,192
Convertible preferred stock, par value (in dollars per share)		$ 0.0001		$ 0.0001		$ 0.0001
Convertible preferred stock shares issued value
Hema Diagnostic Systems, LLC
Net (loss) attributable to noncontrolling interests				(122,692)
Investment in subsidiary by noncontrolling interest				$ 133,679
B-H Sanford, LLC
Common stock issued upon conversion of preferred stock							25,200,000
Salvo
Common stock issued upon conversion of preferred stock								3,354,645
Moscato
Common stock issued upon conversion of preferred stock								3,276,000
Remain To Be Issued
Common stock issued						349,545
Series G Convertible Preferred Stock
Common stock issued												489,993		210,000
Converted stock amount, payment to holder												$ 350		$ 150
Common stock issued as "make-whole payments" on conversions of preferred stock												222,726		98,448
Series F Convertible Preferred Stock
Common stock issued														168,000
Converted stock amount, payment to holder														$ 120
Common stock issued as "make-whole payments" on conversions of preferred stock														88,935
Regentys
Non-controlling interest	$ (9,870,762)
LOI Terms	Pursuant to the Company’s acquisition of Regentys on January 7, 2019 to acquire a 51% interest, the Company was issued 12,048,161 shares of Regentys common stock. As of January 31, 2019, Regentys had a total of 18,623,278 shares of common stock and 2,793,192 Series A voting preferred stock for a total of 21,416,470 total voting shares outstanding. As such, there are 9,368,309 of shares that belong to non-controlling interest shareholders which represents a 43.74% non-controlling interest.
Olaregen
Non-controlling interest									$ (11,999,559)
LOI Terms	Pursuant to the Company’s acquisition of Olaregen on January 7, 2019 to acquire a 51% interest, the Company was issued 3,282,632 shares of Olaregen common stock. As of January 31, 2019, Olaregen had a total of 5,648,819 shares of common stock and 592,683 Series A voting preferred stock for a total of 6,241,502 total voting shares outstanding. As such, there are 2,958,870 of shares that belong to non-controlling interest shareholders which represents a 47.41% non-controlling interest.
Post Reverse Stock Split
Common stock issued															4,830,000
Net Purchase Price
Common stock issued															5,947,431
After Closing
Common stock issued															420
At Closing
Common stock issued															1,117,011